D.B. Root & Company’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,011
Closed -$350K 185
2024
Q1
$350K Hold
4,011
0.12% 139
2023
Q4
$387K Sell
4,011
-395
-9% -$38.1K 0.14% 127
2023
Q3
$390K Buy
4,406
+33
+0.8% +$2.92K 0.15% 123
2023
Q2
$379K Buy
4,373
+290
+7% +$25.1K 0.14% 133
2023
Q1
$397K Buy
4,083
+1
+0% +$97 0.16% 122
2022
Q4
$422K Sell
4,082
-299
-7% -$30.9K 0.18% 115
2022
Q3
$371K Sell
4,381
-7
-0.2% -$593 0.17% 116
2022
Q2
$363K Sell
4,388
-3,223
-42% -$267K 0.16% 128
2022
Q1
$586K Buy
7,611
+34
+0.4% +$2.62K 0.22% 111
2021
Q4
$669K Sell
7,577
-152
-2% -$13.4K 0.24% 106
2021
Q3
$597K Sell
7,729
-1,521
-16% -$117K 0.23% 110
2021
Q2
$771K Sell
9,250
-82
-0.9% -$6.84K 0.29% 96
2021
Q1
$704K Buy
9,332
+2,336
+33% +$176K 0.28% 96
2020
Q4
$613K Sell
6,996
-26
-0.4% -$2.28K 0.24% 105
2020
Q3
$534K Buy
7,022
+783
+13% +$59.5K 0.21% 122
2020
Q2
$769K Sell
6,239
-220
-3% -$27.1K 0.33% 81
2020
Q1
$545K Buy
6,459
+275
+4% +$23.2K 0.28% 92
2019
Q4
$522K Buy
6,184
+2,260
+58% +$191K 0.23% 120
2019
Q3
$264K Sell
3,924
-175
-4% -$11.8K 0.12% 171
2019
Q2
$351K Sell
4,099
-45
-1% -$3.85K 0.16% 155
2019
Q1
$368K Buy
4,144
+394
+11% +$35K 0.16% 150
2018
Q4
$319K Sell
3,750
-2,800
-43% -$238K 0.16% 147
2018
Q3
$635K Sell
6,550
-2,110
-24% -$205K 0.28% 108
2018
Q2
$816K Buy
8,660
+345
+4% +$32.5K 0.39% 91
2018
Q1
$674K Buy
+8,315
New +$674K 0.36% 96